The beyond-use date has passed Compounded medications have beyond-use dates (BUDs), not expiration dates
Because of its stimulant properties, long-term use is generally not advised, which may lead to rebound weight gain once the treatment is stopped
Compounded semaglutide, while potentially cheaper, lacks the same regulatory oversight, raising concerns about consistency and safety
Heres a quick example: If your pharmacy enrolls 200 patients into a monthly weight loss subscription at $200 each (medication + consultation + support), thats $40,000 in monthly revenue
This includes identifying the key residues involved in binding and analyzing the specific interactions contributing to inhibitor binding
This approach helps ensure a smoother experience while adjusting to the new medications and reduces the risk of unwanted side effects